Assisted Suicide in Switzerland

NCT ID: NCT04261088

Last Updated: 2025-12-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-03

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

Researchers want to learn more about how the Swiss model of assisted suicide works. To do this, they have interviewed 25 Swiss experts. The researchers will draw on research in the fields of ethics, law, and medicine to analyze the transcripts.

Objective:

To describe the practice of assisted suicide in Switzerland and to study how the policy is carried out, how the right-to-die societies work, and the ethical implications of the practice.

Eligibility:

Swiss experts in the field of assisted suicide

Design:

The study includes 25 interviews that have already been conducted. The participants were:

* academics
* doctors and others in medical care
* a government official
* representatives of right-to-die societies.

Researchers will analyze the data using qualitative methods. Two researchers will develop a coding scheme and code the texts and analyze the data.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Switzerland is the only country in the world that enables assisted suicide by lay people, i.e.,

people who are not physicians. All other countries that have adopted aid-in-dying legislation

require that a physician provides this assistance. This project probes the reasons for adopting this policy, and the advantages and the disadvantages of the Swiss model at the end of life. Are the Swiss aid-in-dying volunteers able to provide well-informed assistance to patients in need? Is the Swiss model one to be followed by other nations? The project will focus on the work of the Swiss aid-in-dying societies. The study draws on research in the fields of ethics, law and medicine. Its novelty lies in incorporating different methods of analysis, reflecting on the right to die with dignity within a liberal framework that aims to respect fundamental human rights.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Assisted Suicide

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experts in Swiss assisted suicide

Persons in Switzerland who are experts in how assisted suicide is practiced. We will beexamining already collected interviews.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

The study includes 25 interviews with Swiss experts that have been conducted.

* Gender: Men 14, Women 11
* Backgrounds of interviewees: Academics 14, Physicians and other medical care 6, Right to die associations 4, Government official 1
* Race and ethnicity: All white Swiss.
* Age range: Unknown, but all are adults.
* No vulnerable populations.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health Clinical Center (CC)

NIH

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Scott Y Kim, M.D.

Role: PRINCIPAL_INVESTIGATOR

National Institutes of Health Clinical Center (CC)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20-CC-N059

Identifier Type: -

Identifier Source: secondary_id

999920059

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.